1. "Thoracic Oncology"
Formats
  1. Meeting Abstract (1694)
  2. Journal Article (1416)
  3. Review (80)
  4. Editorial (56)
  5. Book Section (35)
  6. Guidelines (24)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3351)
  2. Solid Tumor Oncology Division (3351)
  3. Thoracic Oncology (3351)
  4. GSK Faculty (1056)
  5. Department of Pathology and Laboratory Medicine (797)
  6. Human Oncology and Pathogenesis Program (625)

More Groups

People
  1. Mark Kris (869)
  2. Alexander Drilon (631)
  3. Gregory Riely (599)
  4. Charles Rudin (488)
  5. Marc Ladanyi (414)
  6. Matthew Hellmann (411)

More People

Years
  1. 2025 (73)
  2. 2024 (270)
  3. 2023 (272)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (692)
  2. Journal of Thoracic Oncology (513)
  3. Annals of Oncology (277)
  4. Clinical Cancer Research (156)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (769)
  2. Elsevier Inc. (734)
  3. American Association for Cancer Research (383)
  4. Oxford University Press (350)
  5. Nature Publishing Group (148)
  6. Elsevier Science, Inc. (78)

More Publishers

Results (3351)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Quantifying the expanding landscape of clinical actionability for patients with cancer
    Journal Article

    Suehnholz, S. P.; Nissan, M. H.; Zhang, H.; Kundra, R.; Nandakumar, S.; Lu, C.; Carrero, S.; Dhaneshwar, A.; Fernandez, N.; Xu, B. W.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Brief report: Tyrosine kinase inhibitors for lung cancers that inhibit MATE-1 can lead to “false” decreases in renal function
    Journal Article

    Chen, M. F.; Harada, G.; Liu, D.; DeMatteo, R.; Falcon, C.; Wilhelm, C.; Kris, M. G.; Drilon, A.; Gutgarts, V.
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation
    Journal Article

    Thor, M.; Fitzgerald, K.; Apte, A.; Hun Oh, J.; Iyer, A.; Odiase, O.; Nadeem, S.; Yorke, E. D.; Chaft, J.; Wu, A. J.; more...
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Honing in on the hospital-at-home model
    Editorial

    Mullangi, S.; Daly, B.
    Mayo Clinic Proceedings: Digital Health (2023)

    Fulltext@MSK | Save
  • Important considerations for real-world analysis of neurotrophic tyrosine receptor kinase fusion cancer and tropomyosin receptor kinase inhibitors
    Correspondence

    Brose, M. S.; Hong, D. S.; Drilon, A.
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Amplification of wild-type RET represents a novel molecular subtype of several cancer types with clinical response to selpercatinib
    Journal Article

    Gandhi, M. M.; Ricciuti, B.; Harada, G.; Repetto, M.; Gildenberg, M. S.; Singh, A.; Li, Y. Y.; Gagné, A.; Wang, X.; Aizer, A.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Response to repotrectinib after development of NTRK resistance mutations on first- and second-generation TRK inhibitors
    Journal Article

    Chen, M. F.; Yang, S. R.; Shia, J.; Girshman, J.; Punn, S.; Wilhelm, C.; Kris, M. G.; Cocco, E.; Drilon, A.; Raj, N.
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and genomic features of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer
    Journal Article

    Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Preeshagul, I.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Understanding genomic and social determinants of cancer immunotherapy outcome across ancestry
    Meeting Abstract

    Fong, C. J.; Waters, M.; Pichotta, K.; Jee, J.; Jutagir, D. R.; Ma, D.; Perea-Chamblee, T.; Kim, S.; Arora, K.; Mastrogiacomo, B.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Early-stage anaplastic lymphoma kinase (ALK)-positive lung cancer: A narrative review
    Review

    Chen, M. F.; Chaft, J. E.
    Translational Lung Cancer Research (2023)

    Fulltext@MSK | Save